PULSE
LIVE

Serial Number

79437917

Owner

Celyntra Therapeutics SA

Filing Date

Oct 21, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PULSE Trademark

Serial Number: 79437917

PULSE is a trademark filed by Celyntra Therapeutics SA on October 21, 2025. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Celyntra Therapeutics SA (9 trademarks)

Rue Edouard Belin 2

Entity Type: 33

Trademark Details

Filing Date

October 21, 2025

Registration Date

Not Registered

Goods & Services

Custom manufacturing of cell culture and cell therapy and gene edited cell therapy apparatus and equipment for others; custom manufacture of medicines; custom manufacture of biopharmaceuticals, namely, therapeutic cells, laboratory-modified cells, and gene edited cells to prevent or treat conditions or diseases that can be transferred into the body, for others; information, advice and consultancy in relation to all the aforesaid.

Platform-as-a-service [PaaS] in the field of cell therapy, and cell therapy development; providing temporary use of a a web-based platform that offers tools, technologies, processes and data analysis capabilities for researchers and scientists to streamline the development and characterization of cell lines; providing temporary use of a technological platform for the manufacturing of cell-based therapies, including technology, processes, and data analytics capabilities for process optimization and quality control; platform-as-a-service [PaaS] for monitoring patient health; laboratory research in the field of biotechnology; scientific research, design and technological development services in biotechnology, the pharmaceutical and medical industry; scientific research, design and development of scientific cell culture, cell therapy or gene edited cell therapy equipment and apparatus; scientific research, design and development of cell culture, cell therapy or gene edited cell therapy manufacturing equipment, manufacturing systems and manufacturing processes for others; scientific consultation services in the field of biotechnology, specifically in relation to cell culture, cell therapy, or gene edited cell therapy manufacturing; providing information with respect to scientific research in the field of stem cells, cell therapy and edited cell gene therapy; initial set-up, configuration, and calibration, of scientific apparatus, machines and equipment used for cell culture, cell therapy and edited cell gene therapy; industrial biotechnology statistical analysis to extract insights from cell line development experiments and data; research and development in the field of cells, therapeutic cells, cell therapies, cellular therapies and gene edited cell therapies; culturing of cells for scientific research purposes.

Filing History

REFUSAL PROCESSED BY IB
May 28, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 13, 2026 RFCS
REFUSAL PROCESSED BY MPU
May 13, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 28, 2026 RFCR
NON-FINAL ACTION WRITTEN
Mar 27, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 2, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 2, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 27, 2025 REPR